Nuage Therapeutics
SpainEntry
2023
Hold
3yr
Status
Active
Who owns Nuage Therapeutics?
Nuage Therapeutics is a Spanish Biotech company, currently owned by Sofinnova Partners since 2023 and Asabys Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Asabys PartnersSabadell Asabys Health Innovation Investments II · 2023 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2023 · present
Sofinnova PartnersActive
2023 · present(3yr) · Sofinnova Capital X · 2021 · Life Sciences VC
Asabys PartnersActive
2023 · present(3yr) · Sabadell Asabys Health Innovation Investments II · 2023 · Life Sciences VC
More from Sabadell Asabys Health Innovation Investments II
Other portfolio companies in the same fund.
France
BelgiumMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Nuage Therapeutics?
Nuage Therapeutics is currently owned by Sofinnova Partners and Asabys Partners, through Sabadell Asabys Health Innovation Investments II, since 2023.
When did Sofinnova Partners and 1 other acquire Nuage Therapeutics?
Sofinnova Partners and 1 other acquired Nuage Therapeutics in 2023.
Who has owned Nuage Therapeutics over time?
Nuage Therapeutics has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital X · since 2023; Asabys Partners · via Sabadell Asabys Health Innovation Investments II · since 2023.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue